TXT In plain English
Company description
NOVO NORDISK LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 18 June 1973; registered for 53 years; registered office reported in GATWICK, WEST SUSSEX, UNITED KINGDOM. Its primary declared activity is 46460 · Wholesale of pharmaceutical goods.
This BritDB profile also contains linked public records: 1 PSC record, 1 trade mark, 15 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- NOVO NORDISK LIMITED
- Company number
- 01118740
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 0 total · 0 outstanding · 0 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2025Next accounts due
30 September 2027Last statement made up to
23 June 2026Next statement due
7 July 2027BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- 7.8%
- Mean bonus gap
- 24.5%
- Women receiving bonus
- 93.0%
- Men receiving bonus
- 92.0%
- Women in top quartile
- 59.0%
- Women in upper middle quartile
- 68.0%
- Women in lower middle quartile
- 66.0%
- Women in lower quartile
- 86.0%
Earlier reporting years (8)
- 250 to 49910.0% median hourly gap
- 500 to 99911.0% median hourly gap
- 250 to 49911.6% median hourly gap
- 250 to 49914.0% median hourly gap
- 250 to 49917.5% median hourly gap
- 250 to 49919.6% median hourly gap
- 250 to 49918.1% median hourly gap
- 250 to 49912.3% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 July 2024 – 31 December 2024
- Filed
- 30 January 2025
- Shortest standard term
- 0 days
- Longest standard term
- 60 days
- E-invoicing offered
- No
- Supply-chain finance
- Not offered
- Payment codes
- No
- Construction retentions
- No qualifying construction contracts
Complete reported payment fields
- Policy regime
- Regime-1
- Financial period started
- Not supplied
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid outside agreed terms
- £0
- Invoices paid in 31–60 days
- 31.0%
- Invoices unpaid due to dispute
- 0.0%
- Maximum contractual payment period
- 60 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Payment terms changed
We have reduced our standard payment terms to 60 days as we had two suppliers that had standard payment terms of 90 days that we have not used since 2023. All other suppliers are within our standard payment terms stated above of 60 days
Reported terms and dispute process
- Standard payment terms
Standard terms range from immediate payment on receipt of invoices to 60 days on receipt of invoices
- Dispute resolution process
Suppliers can get in touch with Novo Nordisk Limited's Accounts Payable department for any invoice or payment queries via email. Disputes are managed directly with the supplier and resolved items are reprocessed. Novo Nordisk Limited is supported by a Global Business Service Centre Accounts Payable team who support suppliers with their queries.
Earlier payment reports (11 shown)
- Average time not suppliedLate-payment rate not supplied
- 32.0 average days to pay14.0% outside terms
- 27.0 average days to pay26.0% outside terms
- 28.0 average days to pay25.0% outside terms
- 23.0 average days to pay16.0% outside terms
- 28.0 average days to pay7.0% outside terms
- 27.0 average days to pay17.0% outside terms
- 27.0 average days to pay16.0% outside terms
- 29.0 average days to pay19.0% outside terms
- 28.0 average days to pay23.0% outside terms
- 28.0 average days to pay24.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Supply-chain transparency
Modern slavery statement
- Organisation
- NOVO NORDISK LIMITED
- Group submission
- No
- Statement period
- 1 January 2024 – 31 December 2024
- Approved
- 17 June 2025
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- Over £500 million
- Years producing statements
- 1 to 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 19 September 2025
Policies described
Freedom of workers to terminate employment Freedom of movement Freedom of association Prohibits any threat of violence, harassment and intimidation Prohibits the use of worker-paid recruitment fees Prohibits compulsory overtime Prohibits child labour Prohibits discrimination Prohibits confiscation of workers' original identification documents Provides access to remedy, compensation and justice for victims of modern slavery
Training described
Your whole organisation Your front line staff Human resources Executive-level staff Procurement staff Your suppliers
Worker engagement and working conditions
Your suppliers Trade unions or worker representative groups Civil society organisations Professional auditors Workers within your organisation Workers within your supply chain Central or local government Law enforcement, such as police, GLAA and other local labour market inspectorates Businesses in your industry or sector
Social audits
Audit conducted by your staff
Grievance mechanisms
Using anonymous whistleblowing services, such as a helpline or mobile phone app Through trade unions or other worker representative groups
Reported risks and mitigations
- Risk: Risks detailed in Modern Slavery Statement published.
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
06 Data protection
ICO fee-payer registration
Novo Nordisk Limited
Registration Z6551295
- Registered from
- 8 April 2002
- Current end date
- 7 April 2027
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
07 Public procurement
Contracts Finder awards
Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products
Supply Chain Coordination Limited · ocds-b5fd17-13650ef2-0040-42d4-98e9-af1283571b69
- Supplier named in award
- Novo Nordisk
- Award value
- £1,067,000,000
- Contract period
- 28 November 2025 – 27 November 2027
- Published
- 3 December 2025
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33140000
- Source release ID
- ocds-b5fd17-13650ef2-0040-42d4-98e9-af1283571b69-2025-12-03T22:35:11Z
Integrated Weight Management Services Pathway Redesign for NHS Mid and South Essex Integrated Care Board
Attain · ocds-b5fd17-881b88f4-a111-43d2-8b56-60a872cae4ca
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £200,999.76
- Contract period
- 1 January 2023 – 31 December 2024
- Published
- 12 July 2023
- Procedure
- Single tender action (below threshold)
- Main CPV
- 85140000
- Source release ID
- ocds-b5fd17-881b88f4-a111-43d2-8b56-60a872cae4ca-2023-07-12T13:21:44+01:00
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England · ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9
- Supplier named in award
- Novo Nordisk
- Award value
- £1
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 13 May 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-711f74f7-430c-4b80-a5e0-b3ce69f928b9-2021-05-13T10:21:38+01:00
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England · ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef
- Supplier named in award
- Novo Nordisk
- Award value
- £228,156,862
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 30 April 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef-2021-04-30T13:00:26+01:00
NHS Framework for the NHS London Region, Branded Medicines - Tranche A
NHS England · ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £191,062,951
- Contract period
- 1 September 2020 – 31 August 2022
- Published
- 15 September 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67-2020-09-15T14:26:04+01:00
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A
NHS England · ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £334,400,000
- Contract period
- 1 July 2020 – 30 June 2022
- Published
- 3 July 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1babd75c-bccc-4e92-ae60-e9319f60f432-2020-07-03T15:59:42+01:00
NHS Framework Agreement - North of England - Tranche B
NHS England · ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef
- Supplier named in award
- NOVO NORDISK LIMITED
- Award value
- £205,535,556
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 25 March 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2774d91d-05e7-400d-a217-4a5ca9db01ef-2020-03-25T08:39:13Z
NHS Midlands and East Branded Medicines - Tranche A
NHS England · ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £418,787,000
- Contract period
- 1 March 2020 – 28 February 2022
- Published
- 13 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-1d021051-40c8-4883-ba04-47625826b7b8-2020-02-13T09:40:57Z
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice
NHS England · ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349
- Supplier named in award
- NOVO NORDISK LIMITED
- Award value
- £188,004,961
- Contract period
- 1 September 2019 – 31 August 2021
- Published
- 17 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8b5e045d-6a03-4c26-b452-fcd5b23d5349-2019-10-17T10:16:17+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
NHS Framework agreement for Branded Medicines - North of England - Tranche A
NHS England · ocds-b5fd17-2e43909f-31cc-4421-9f28-e9e4f18738ed
- Supplier named in award
- NOVO NORDISK LIMITED
- Award value
- £204,551,038
- Contract period
- 1 March 2019 – 28 February 2021
- Published
- 3 May 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-2e43909f-31cc-4421-9f28-e9e4f18738ed-2019-05-03T14:35:17+01:00
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
NHS England Framework Agreement - London - Tranche A
NHS England · ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351
- Supplier named in award
- Novo Nordisk Ltd
- Award value
- £211,435,404
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 7 November 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-7b2dd479-3a52-442f-a080-4372505d9351-2018-11-07T09:28:44Z
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
08 Ownership and control
People with significant control
Novo Nordisk Holding Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- England & Wales
- Legal authority
- Companies Act 2006
- Legal form
- Private Limited Company
- Place registered
- Companies House For England & Wales
- Registration number
- 1329008
- Notified
- 6 April 2016
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
09 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
10 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
11 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
12 Public procurement
Find a Tender links
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
13 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
14 Nature of business
Standard Industrial Classification
15 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
1 procurement process linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
16 Record timeline
Dates in the bulk record
- Confirmation statement
Latest confirmation statement made up to this date
- Accounts
Latest accounts made up to this date
- Incorporation
Company incorporated
17 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.